Novo Nordisk shares slump after drug failure in Alzheimer’s trial
found
a story from Financial Times ✅ › Financial Times
Outcome is blow to one of Europe’s largest listed companies
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.